Colorado BioScience Association Names New Board Members
By: Colorado BioScience Association Date: 04/20/2018
Leaders represent CereScan, Ocugen, Prevacept Infection Control, Sharklet and Zimmer Biomet
DENVER – April 23, 2018 – Colorado BioScience Association (CBSA) announces new members elected to its board of directors. The five new board members were introduced and approved during the organization’s annual board retreat on April 19.
Newly appointed board members
Jim Cloar, Zimmer Biomet, Vice President & Chief Commercial Officer, Spine & Robotics
Gino DiSciullo, Ph.D., Prevacept Infection Control, CEO
Charlie Kang, CFO, Ocugen
Ethan Mann, Ph.D., Sharklet, COO
Steve Warnecke, CereScan, Board Member & CFO; VetDC, Chairman & CFO; Evolutionary Genomics, Chairman & CEO
Gino DiSciullo, Ph.D.
Ethan Mann, Ph.D.
Board members renewing their terms
Larry Blankenship, Evergreen Research, Director
Gary Connell, Sheridan Ross, Co-President, Shareholder
Brent Fassett, Cooley, Partner
Mark Lupa, Ph.D., High Country Venture, Partner
Fintan Steele, Ph.D., SomaLogic, Chief Communications and Culture Officer
Kiki Traylor, M.D., Amgen, Director of State Government Affairs
Steve VanNurden, Fitzsimons Innovation Campus, President & CEO
Dan Wittenberg, Snell & Wilmer, Partner
Shelly Zelin, AlloSource, Vice President of Human Resources
Scott Larson, Board Chairman of CBSA, says:
“It’s an honor to welcome Jim, Gino, Charlie, Ethan and Steve to the CBSA board. They represent leading Colorado digital health, biotech and medical device companies working to advance health care and improve lives. I look forward to drawing on their expertise as CBSA works to shape the future of our sector.”
April Giles, President and CEO of CBSA says:
“Colorado’s rapid growth brings new opportunities and talent to our state. CBSA leads policy and advocates for a business environment that supports all stages of innovation. We extend a warm welcome to our new board members and their perspectives. We also want to thank our outgoing board members for their commitment to Colorado BioScience Association, with a special thanks to our former board chairman Mark Spiecker his leadership and dedicated service to CBSA.”
CBSA board members commit to a three-year term and work in partnership with CBSA staff to support the growth of Colorado’s 720 life science companies.
Connect with CBSA: Twitter @COBioscience, Facebook and LinkedIn
About the Colorado BioScience AssociationColorado BioScience Association champions life science. We serve as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio and mobile digital health companies, research and academic institutions and service providers. Learn more about us at https://cobioscience.com.
Primavera Group for Colorado BioScience Association